Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» exa-cel
exa-cel
13 Therapies Make Clarivate’s 2024 Drugs to Watch List
BioSpace
Wed, 01/10/24 - 06:30 pm
Clarivate
Eylea
Tarpeyo/Kinpeygo
Dato-DXd
Altuviiio
RPL554
exa-cel
lovo-cel
LY-3074828
Akeega
Abrysvo
Talvey
Arexvy
IMAB362
5 FDA Decisions to Watch in Q1
BioSpace
Tue, 01/2/24 - 11:24 am
FDA
Iovance Biotherapeutics
melanoma
lifileucel
Minerva Neurosciences
schizophrenia
roluperidone
Viatris
Mapi Pharma
MS
multiple sclerosis
GA Depot
Madrigal Pharmaceuticals
NASH
resmetirom
Vertex Pharmaceuticals
CRISPR Therapeutics
exa-cel
beta thalassemia
Where Will Vertex Pharmaceuticals Be in 10 Years?
Motley Fool
Mon, 12/4/23 - 09:31 am
Vertex Pharmaceuticals
cystic fibrosis
exa-cel
sickle cell disease
Cell & Gene Therapy Space Gears Up for First CRISPR Approval
BioSpace
Mon, 11/13/23 - 11:48 am
CRISPR
gene therapy
cell therapy
sickle cell disease
exa-cel
Vertex Pharmaceuticals
CRISPR Therapeutics
Bluebird won't play off Vertex in deciding price for its lovo-cel gene therapy, exec says
Fierce Pharma
Tue, 11/7/23 - 11:02 pm
Bluebird Bio
Vertex Pharmaceuticals
exa-cel
lovo-cel
sickle cell disease
drug pricing
As Vertex preps for exa-cel launch, exec touts 'very large' opportunity but tempers early expectations
Fierce Pharma
Tue, 11/7/23 - 11:47 am
Vertex Pharmaceuticals
CRISPR
gene editing
FDA
exa-cel
Two Sickle Cell Disease Gene Therapies May Soon Be Approved By FDA
Forbes
Thu, 11/2/23 - 05:07 pm
sickle cell disease
gene therapy
lovo-cel
exa-cel
Vertex Pharmaceutical
CRISPR Therapeutics
Bluebird Bio
FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study
Yahoo/Reuters
Tue, 10/31/23 - 09:23 pm
Vertex Pharmaceuticals
CRISPR Therapeutics
FDA
gene therapy
exa-cel
Tracking the FDA’s meeting on Vertex, CRISPR’s sickle cell therapy
BioPharma Dive
Tue, 10/31/23 - 10:13 am
FDA
Vertex Pharmaceuticals
CRISPR
sickle cell disease
exa-cel
FDA Flags Off-Target Effects of Vertex, CRISPR’s Sickle Cell Therapy Ahead of Adcomm
BioSpace
Mon, 10/30/23 - 08:09 pm
Vertex Pharmaceuticals
exa-cel
CRISPR
sickle cell disease
FDA
Vertex gearing up for launch as sickle cell therapy review advances
BioPharma Dive
Thu, 10/26/23 - 10:42 pm
Vertex Pharmaceuticals
sickle cell disease
exa-cel
5 FDA decisions to watch in the fourth quarter
BioPharma Dive
Mon, 10/2/23 - 12:00 pm
FDA
Alnylam
Onpattro
ATTR amyloidosis
Vertex Pharmaceuticals
CRISPR Therapeutics
exa-cel
Bluebird Bio
Zynteglo
sickle cell disease
Bristol Myers Squibb
2seventy bio
Abecma
Multiple Myeloma
Amgen
Lumakras
non-small cell lung cancer
Pfizer
estrasimod
ulcerative colitis
First-ever CRISPR-CAS9 therapy, exa-cel, shows promising results
Clinical Trials Arena
Thu, 08/3/23 - 06:28 pm
Vertex Pharmaceuticals
exa-cel
CRISPR
beta thalassemia
9 Highly Anticipated FDA Decisions in Second Half of 2023
BioSpace
Fri, 06/30/23 - 11:52 am
FDA
Eisai
Biogen
Leqembi
Alzheimer's disease
SAGE Therapeutics
zuranolone
postpartum depression
major depressive disorder
Roche
Tecentriq
non-small cell lung cancer
CRISPR Therapeutics
Bluebird Bio
lovo-cel
exa-cel
BrainStorm Cell Therapeutics
NurOwn
Could This Move Make Vertex's Next Blockbuster Even Bigger?
Motley Fool
Wed, 04/12/23 - 11:34 am
Vertex Pharmaceuticals
exa-cel
beta thalassemia
sickle cell disease
Vertex and CRISPR Therapeutics Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
Yahoo/Businesswire
Mon, 04/3/23 - 10:09 am
Vertex Pharmaceuticals
CRISPR Therapeutics
sickle cell disease
beta thalassemia
FDA
exa-cel
Vertex pays ImmunoGen $15M to use antibody-drug conjugates to improve CRISPR therapy
Fierce Biotech
Wed, 03/1/23 - 09:56 am
Vertex Pharmaceuticals
Immunogen
gen editing
antibody-drug conjugate
exa-cel
Vertex Teases Launch of Landmark CRISPR Therapy
BioSpace
Thu, 02/9/23 - 10:45 am
Vertex Pharmaceuticals
exa-cel
sickle cell disease
CRISPR
EMA validates Vertex's CRISPR application, clearing barrier on road to landmark approval
Fierce Biotech
Thu, 01/26/23 - 10:53 am
Vertex Pharmaceuticals
CRISPR Therapeutics
EMA
CRISPR
sickle cell disease
exa-cel
Vertex given green light to seek US approval of CRISPR-based therapy
BioPharma Dive
Wed, 09/28/22 - 12:01 am
Vertex Pharmaceuticals
CRISPR
CRISPR Therapeutics
FDA
exa-cel
beta thalassemia
sickle cell disease